Skip to content

To investigate the effectiveness of tea tree oil gel on the treatment of mild to moderate facial seborrheic dermatitis in comparison with placebo

To investigate the effectiveness of tea tree oil gel on the treatment of mild to moderate facial seborrheic dermatitis in comparison with placebo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013072314117N1
Enrollment
54
Registered
2013-08-18
Start date
2013-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seborrhoeic dermatitis. seborrhoeic dermatitis

Interventions

Intervention 1: Intervention group: the groups will be treated topically with tea tree oil gel, three times per day for one month. Intervention 2: Control group: Base gel without drug substances.
Treatment - Drugs
Placebo
Intervention group: the groups will be treated topically with tea tree oil gel, three times per day for one month.
Control group: Base gel without drug substances

Sponsors

Vice chancellor for research, Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with mild-to-moderate facial seborrheic dermatitis diagnosis, age 18 to 45 years old. Exclusion criteria: pregnant or breastfeeding women; people under 18 or over 45 years, patients with active, localized, or systemic infection, use of products for seborrheic dermatitis or systemic steroids within the last two weeks ,known allergy to lotions or moisturizers .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement of seborrheic dermatitis symptoms. Timepoint: After 2 weeks intervention and after 4 weeks intervention. Method of measurement: Clinical examination and comparison with previous conditions.

Secondary

MeasureTime frame
Adverse effect. Timepoint: After 2 weeks intervention and after 4 weeks intervention. Method of measurement: Clinical examination and comparison with previous conditions.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAkram Beheshti

Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran

abeheshti@qums.ac.ir+98 28 1336 0084

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026